Evidence map›Paper›PMID 30912655›Full record

ArticleJournal of the American Chemical Society2019

Mapping a Systematic Ribozyme Fitness Landscape Reveals a Frustrated Evolutionary Network for Self-Aminoacylating RNA.

Abe D Pressman, Ziwei Liu, Evan Janzen, Celia Blanco, Ulrich F Müller, Gerald F Joyce, Robert Pascal, Irene A Chen

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Coevolution of RNase P and the ribosome.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Rapid discovery of functional RNA domains.Nucleic acids research · 2025
    Article
  8. Principles ofJournal of the Royal Society, Interface · 2025
    Article
  9. Article
  10. Article
  11. Bioengineering hybrid artificial life.Frontiers in bioinformatics · 2025
    Review
  12. Article
  13. Evolution of the substrate specificity of an RNA ligase ribozyme from phosphorimidazole to triphosphate activation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. A potential role for RNA aminoacylation prior to its role in peptide synthesis.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abe D PressmanDepartment of Chemistry and Biochemistry 9510 , University of California , Santa Barbara , California 93106 , United States.
Ziwei LiuMRC Laboratory of Molecular Biology , Cambridge Biomedical Campus , Cambridge CB2 0QH , U.K.ORCID 0000-0002-1812-2538
Evan JanzenDepartment of Chemistry and Biochemistry 9510 , University of California , Santa Barbara , California 93106 , United States.
Celia BlancoDepartment of Chemistry and Biochemistry 9510 , University of California , Santa Barbara , California 93106 , United States.
Ulrich F MüllerDepartment of Chemistry and Biochemistry , University of California , San Diego , California 92093 , United States.
Gerald F JoyceSalk Institute for Biological Studies , La Jolla , California 92037 , United States.ORCID 0000-0003-0603-2874
Robert PascalIBMM, CNRS, University of Montpellier, ENSCM , 34090 Montpellier , France.ORCID 0000-0001-9579-2503
Irene A ChenDepartment of Chemistry and Biochemistry 9510 , University of California , Santa Barbara , California 93106 , United States.ORCID 0000-0001-6040-7927

Funding

Acquisition of Covaris E220 and Sciclone G3 systems for high throughput sequencinS10OD010786 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI COMAI, LUCA · 2012 to 2012
$311k
Medical Research Council MC_UP_A024_1009NIH HHS S10 OD010786
6 · The paper itself

Abstract

Molecular evolution can be conceptualized as a walk over a "fitness landscape", or the function of fitness (e.g., catalytic activity) over the space of all possible sequences. Understanding evolution requires knowing the structure of the fitness landscape and identifying the viable evolutionary pathways through the landscape. However, the fitness landscape for any catalytic biomolecule is largely unknown. The evolution of catalytic RNA is of special interest because RNA is believed to have been foundational to early life. In particular, an essential activity leading to the genetic code would be the reaction of ribozymes with activated amino acids, such as 5(4 H)-oxazolones, to form aminoacyl-RNA. Here we combine in vitro selection with a massively parallel kinetic assay to map a fitness landscape for self-aminoacylating RNA, with nearly complete coverage of sequence space in a central 21-nucleotide region. The method (SCAPE: sequencing to measure catalytic activity paired with in vitro evolution) shows that the landscape contains three major ribozyme families (landscape peaks). An analysis of evolutionary pathways shows that, while local optimization within a ribozyme family would be possible, optimization of activity over the entire landscape would be frustrated by large valleys of low activity. The sequence motifs associated with each peak represent different solutions to the problem of catalysis, so the inability to traverse the landscape globally corresponds to an inability to restructure the ribozyme without losing activity. The frustrated nature of the evolutionary network suggests that chance emergence of a ribozyme motif would be more important than optimization by natural selection.

Indexed as

AcylationBiocatalysisMolecular StructureOxazoloneRNARNA, CatalyticOxazoloneRNARNA, Catalytic

Identifiers

PMID30912655
PMCPMC6548421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.